ArticleBMJ open ophthalmology2025
Multidimensional imaging model for diagnosing primary open-angle glaucoma using fundus photographs and optical coherence tomography images.
Article in BMJ open ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence assisted quantitative analysis of fundus structural and vascular alterations reveals fundus tessellation as a robust biomarker of myopia severity.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo develop a multidimensional imaging model to detect primary open-angle glaucoma (POAG) by combining fundus photographs with the retinal nerve fibre layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL) thickness maps and deviation maps.
methods1054 eyes of 546 patients were included. Images were randomly divided into training, validation and test datasets at 64%, 16% and 20%. Four basic convolutional neural network algorithms were used to develop the multidimensional imaging model by combining fundus photographs, RNFL and GCIPL deviation maps, with RNFL and GCIPL thickness maps. POAG structure damage was defined as RNFL and GCIPL thinning with neuroretinal rim thinning.
resultsMultidimensional imaging model obtained an area under the receiver operating characteristic curve (AUC) of 0.970 (95% CI 0.958 to 0.979), which was superior to the fundus photographs model (AUC, 0.945 (95% CI 0.929 to 0.958); p<0.05), RNFL and GCIPL deviation maps model (AUC, 0.931 (95% CI 0.915 to 0.946); p<0.001), RNFL and GCIPL thickness maps model (AUC, 0.958 (95% CI 0.944 to 0.969)) in the test dataset. There was a significant difference between the multidimensional imaging model (AUC, 0.969 (95% CI 0.934 to 0.988)) and three glaucoma ophthalmologists (attending ophthalmologist 1: AUC, 0.847; attending ophthalmologist 2: AUC, 0.842; resident ophthalmologist: AUC, 0.755; p<0.001 for both) in one fold of the test dataset. Furthermore, the overall AUCs were lower in the myopic group than in the non-myopic group. The overall AUC for lesion detection by each model (p=0.159) was: low myopia group (AUC, 0.968 (95% CI 0.940 to 0.985)) > moderate myopia group (AUC, 0.966 (95% CI 0.936 to 0.984)) >high myopia group (AUC, 0.958 (95% CI 0.927 to 0.978)). The multidimensional imaging model outperformed unimodal models in diagnosing myopia combined with POAG.
conclusionThe multidimensional imaging model, combining fundus photographs, RNFL and GCIPL deviation maps, with RNFL and GCIPL thickness maps, could perform better than unimodal models. Its potential to improve the diagnostic accuracy of myopia combined with POAG for various myopia levels is promising. This means it could be a valuable tool for assisting with POAG diagnosis in the clinic, offering hope for improved patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.